Mindray(SZ:300760) Ge Long Hui A P P·2025-08-28 02:52Core Viewpoint - Mindray Medical reported strong financial performance for the first half of 2025, with significant revenue and profit growth, alongside a robust dividend distribution plan [1] Financial Performance - The company achieved operating revenue of 16.743 billion yuan and a net profit attributable to shareholders of 5.069 billion yuan during the reporting period [1] - The net cash flow from operating activities was 3.922 billion yuan [1] Dividend Distribution - Mindray Medical announced a second interim dividend plan for 2025, proposing a cash dividend of 1.31 yuan per share (before tax), totaling 1.588 billion yuan [1] - Combined with the first interim dividend of 1.71 billion yuan (before tax), the total cash dividends for 2025 will reach 3.298 billion yuan, representing 65.06% of the net profit for the first half of 2025 [1] Historical Dividend Record - The company has maintained a consistent dividend policy since its IPO, distributing dividends for seven consecutive years, with a cumulative total of 35.7 billion yuan (including 2 billion yuan for share repurchases) [1] - The total dividends distributed are six times the IPO fundraising amount of 5.934 billion yuan [1]